Try our Advanced Search for more refined results

Peregrine Knew Cancer Drug Trials Were Bunk, 9th Circ. Told

By Daniel Siegal (May 4, 2016, 11:07 PM EDT) -- A Peregrine Pharmaceuticals shareholder urged the Ninth Circuit on Wednesday to revive his stock-drop class action alleging the drugmaker puffed up its share price with false positive news about its lung cancer drug bavituximab, arguing the company must have known that data came from a flawed experiment....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!